Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 800 878 7930


FDA MedWatch Drug Alerts

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


 

November 3rd, 2009
FDA Purchases Fake H1N1 Swine Flu Drugs

Consumers are being warned by the U.S. Food and Drug Administration today to be cautious if purchasing prescription drugs through the Internet meant to detect, prevent, fix or completely cure the H1N1 swine flu virus. The FDA made the warning after purchasing and examining products that were sold as Tamiflu (oseltamivir) on suspicious websites. It is [...]

October 1st, 2009
Acetaminophen linked to liver failure and death

Acetaminophen, an ingredient in many common prescription and non-prescription drugs, has been recently linked to liver failure and death. It is found in Extra Strength Tylenol, NyQuil Cold & Flu Relief Liquid, Excedrin, and Canadian prescription drugs Percocet and Vicodin.

September 3rd, 2009
FDA Maintains Insulin Theft Alert

The U.S. FDA warns the public that there is a potential for stolen long-acting insulin Levemir, produced by Novo Nordisk Inc, to still be active on the market. Based on the FDA’s evidence, their proof suggests that the stolen insulin was improperly stored and handled, leaving the public vulnerable to risk. Many patients have informed the FDA of adverse side effects they experienced after using a vial from the stolen group, their glucose levels were incorrectly managed.

August 19th, 2009
FDA Advises of Pure Red Cell Aplasia Found in CellCept Patients

The U.S. FDA and Roche have informed healthcare practitioners that patients being treated with CellCept, have reported cases of Pure Red Cell Aplasia, also known as PRCA.

August 11th, 2009
Safety Concerns Cease NHLBI’s Sickle Cell, Pulmonary Hypertension Trial

The National Heart, Lung and Blood Institute (NHLBI) has halted a clinical trial involving drug treatment tests for pulmonary hypertension in adults who suffer from sickle cell disease.

August 10th, 2009
US FDA Communicates Melamine Testing Recommendations

The US FDA recently issued a recommendation advising that certain pharmaceutical components used in the production or composition of drug products should be tested for melamine.

August 7th, 2009
FDA Warns Consumers of Body Building Products Promoted as Dietary Supplements

The US FDA has advised healthcare practitioners and consumers of current safety information with regard to body building and increase muscle mass products, these products are commonly described as a substitute for anabolic steroids (used to increase muscle mass and strength), available both online and in retail establishments.

August 7th, 2009
Steam Dietary Supplement Pulled From Pharmacy Shelves

The FDA’s laboratory analysis discovered sulfoaildenafil, an analog of sildenafil. Sildenafil is a key ingredient in the FDA-approved drug for erectile dysfunction, which makes Steam an unsanctioned drug.

August 7th, 2009
FDA Demands TNF Blockers to Include Cancer Warnings

The US FDA requires TNF blockers to include firm detailed warnings in the prescribing information. The warnings, which also involves an up to date box warning, spotlights the increase chance of cancer in children and adolescents who first obtain the drug to treat juvenile rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and other inflammatory diseases.

August 7th, 2009
FDA Warns: Clarcon Skin Products Present Health Threats

The US FDA cautions consumers of the harmful effects Clarcon skin products are having on the skin. They urge consumers to cease all usage of Clarcon Biological Chemistry Laboratory skin sanitizer or protectants, because of hazardous bacteria.

  • Page 1 of 2
  • 1
  • 2
  • >

SEARCH

Search for Medication or Types of Conditions

SHOPPING CART

cart

Items in cart: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

try
download order form

ALL PRESCRIPTION DRUGS FILLED BY:

Medicine Shoppe Pharmacy
148 #9 31205 Old Yale Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan

 

TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930